Quantum Immunologics, Inc. is a pharmaceutical research startup founded in 2008. Specializing in biotechnology and health care within the platforms industry, the company received a significant $1.63M Venture Round investment on 25th September 2010. Although details about the investors and headquarters are currently unavailable, Quantum Immunologics, Inc. continues to be a player in the biotech and healthcare sectors, making notable strides in pharmaceutical research.
Quantum Immunologics, Inc.
Founded 2008
6 employees
Venture round
Total: $7.54M
Biotechnology, Health Care +1
General Information
Company Name
Quantum Immunologics, Inc.
Founded Year
2008
Employees
6
Industries
Biotechnology, Health Care, Platforms
Funding Stage
Venture round
BounceWatch is an independent company data service, not affiliated with Quantum Immunologics, Inc.. To contact Quantum Immunologics, Inc., visit quantumimmunologics.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Quantum Immunologics, Inc. compare?
A PDF of Quantum Immunologics, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Quantum Immunologics, Inc. soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Quantum Immunologics, Inc.
Business keywords: cancer, immunotherapy, development, production, individualized treatment, breast cancer, cancer monitoring, immune response, Tampa, Florida
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $1.63M | - |
|
25 Sep 2010 |
| Series A | $2.20M | 1 |
|
15 Sep 2009 |
| Venture Round | $3.70M | - |
|
18 Jun 2009 |
Quantum Immunologics, Inc. Alternatives & Competitors
View All Alternatives
Quantum Immunologics, Inc. vs
ImmunoCellular Therapeutics Ltd
United States
Pioneering immune-based therapies to harness the body's defenses against cancer through advanced imm...
Grant
11 employees
Biotechnology, Health Care
Quantum Immunologics, Inc. vs
ImmunoGenesis, Inc.
United States
Re-envisioning cold tumor treatment. Our deliberate drug development strategy targets mechanisms of...
Venture round
14 employees
Biotechnology, Health Care
Quantum Immunologics, Inc. vs
Tolerx, Inc.
United States
Tolerx, Inc., a world leader in immunology, has a portfolio of innovative, first-in-class drug candi...
Venture round
9 employees
Biotechnology, Health Care
FAQ About Quantum Immunologics, Inc.
Pharmaceutical research
Quantum Immunologics, Inc. was founded in 2008.
Quantum Immunologics, Inc. operates in Biotechnology, Health Care and Platforms. Its work centres on cancer, immunotherapy, development and production.
Quantum Immunologics, Inc. has approximately 6 employees.
Quantum Immunologics, Inc. has completed 3 funding rounds, raising a total of $7.54M. The latest funding stage is Venture round.
Top alternatives and competitors to Quantum Immunologics, Inc. include ImmunoCellular Therapeutics Ltd, ImmunoGenesis, Inc., Tolerx, Inc., Coley Pharmaceutical Group, GLIKNIK INC.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Quantum Immunologics, Inc. and ImmunoCellular Therapeutics Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Quantum Immunologics, Inc., https://bouncewatch.com/company/quantum-immunologics, updated 27 December 2024. When citing, please name BounceWatch and link this page.
